This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Siena Biotech S.p.a., Wyeth. Active years: 2012.
Company Filing History:
1 out of 11 
1 out of 1,309 
Years Active: 2012
Title: Carmela Pratelli: Innovator in Neurological Therapeutics
Introduction
Carmela Pratelli is a notable inventor based in Siena, Italy. She has made significant contributions to the field of neuroscience through her innovative research and development of therapeutic compounds. Her work focuses on modulating alpha7 nicotinic acetylcholine receptors, which play a crucial role in various neurological and psychiatric disorders.
Latest Patents
Carmela Pratelli holds 1 patent for her invention titled "Modulators of α7 nicotinic acetylcholine receptors and therapeutic uses thereof." This patent provides compounds of formula (I) and compositions that can be used to modulate alpha7 nicotinic acetylcholine receptors. The invention outlines methods for making these compounds and their therapeutic applications in treating a variety of disorders, diseases, and conditions, particularly those affecting the neurological, psychiatric, and inflammatory systems.
Career Highlights
Throughout her career, Carmela has worked with prominent companies in the biotechnology sector, including Wyeth and Siena Biotech S.p.a. Her experience in these organizations has allowed her to develop her expertise in drug discovery and therapeutic applications.
Collaborations
Carmela has collaborated with talented individuals in her field, including Chiara Ghiron and Arianna Nencini. These partnerships have contributed to her innovative research and the advancement of her patented technologies.
Conclusion
Carmela Pratelli is a pioneering inventor whose work in modulating alpha7 nicotinic acetylcholine receptors has the potential to impact the treatment of various neurological and psychiatric disorders. Her contributions to the field highlight the importance of innovation in therapeutic development.